CareCloud, Inc. (CCLD) vs Neumora Therapeutics, Inc. Common Stock (NMRA)
A side-by-side comparison of CareCloud, Inc. and Neumora Therapeutics, Inc. Common Stock across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CCLD
CareCloud, Inc.
$2.05HealthcareDelayed quote: Oct 6, 2026, 11:35 AM EDT
NMRA
Neumora Therapeutics, Inc. Common Stock
$0.51HealthcareDelayed quote: Oct 6, 2026, 11:35 AM EDT
Total return — CCLD vs NMRA
growth of $100 · dividends reinvested · last 3yCCLD +59.4% (+16.8%/yr)NMRA -96.8% (-68.1%/yr)CCLD compounded faster over this window
Log scale — wide-divergence pair
CCLD NMRA
CCLD vs NMRA: by the numbers
- •NMRA is the larger company ($94M vs $87M market cap).
- •CCLD is profitable (6.21% net margin) while NMRA runs a net loss (0.00%).
Metrics side by side
Valuation
| Metric | CCLD | NMRA |
|---|---|---|
| P/E ratio | 29.30 | N/A |
| Forward P/E | 7.44 | N/A |
| P/S ratio | 0.68 | N/A |
| P/B ratio | 4.99 | 2.11 |
| EV / EBITDA | 4.64 | N/A |
| FCF yield | 24.94% | N/A |
Profitability
| Metric | CCLD | NMRA |
|---|---|---|
| Gross margin | 46.51% | 0.00% |
| Operating margin | 7.31% | 0.00% |
| Net margin | 6.21% | 0.00% |
| ROE | 45.93% | -477.87% |
| ROIC | 12.79% | -216.05% |
Growth (annualized)
| Metric | CCLD | NMRA |
|---|---|---|
| Revenue CAGR (5Y) | 0.18% | N/A |
| Total return CAGR (5Y) | -23.18% | N/A |
Frequently asked
- Is CCLD or NMRA more profitable?
- CCLD runs the higher net margin — CCLD at 6.21% versus NMRA at 0.00%.
Go deeper
Dig into the metrics
CareCloud P/E ratioCareCloud ROENeumora Therapeutics, Inc. Common Stock ROECareCloud operating marginNeumora Therapeutics, Inc. Common Stock operating marginCareCloud revenue growthNeumora Therapeutics, Inc. Common Stock revenue growthCareCloud free cash flowNeumora Therapeutics, Inc. Common Stock free cash flow
CareCloud & Neumora Therapeutics, Inc. Common Stock appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.